Minimal data reporting standards for serological testing for histocompatibility.

[1]  C. Canter,et al.  Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children‐04 (CTOTC‐04) in pediatric heart transplantation , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  J. Friedewald,et al.  Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  N. Reinsmoen,et al.  Comprehensive assessment for serum treatment for single antigen test for detection of HLA antibodies. , 2017, Human immunology.

[4]  Olivier Aubert,et al.  Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment. , 2017, Journal of the American Society of Nephrology : JASN.

[5]  G. Serban,et al.  Comparative Assessment of Anti-HLA Antibodies Using Two Commercially Available Luminex-Based Assays , 2017, Transplantation direct.

[6]  A. Loupy,et al.  Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis. , 2017, Kidney international.

[7]  R. Bray,et al.  The Road to HLA Antibody Evaluation: Do Not Rely on MFI , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  X. Jouven,et al.  Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss. , 2017, Journal of the American Society of Nephrology : JASN.

[9]  A. Zeevi,et al.  Significance of Anti-HLA Antibodies on Adult and Pediatric Heart Allograft Outcomes , 2017, Front. Immunol..

[10]  D. Min,et al.  Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes? , 2017, Journal of immunology research.

[11]  C. Di Primo,et al.  Deciphering IgM interference in IgG anti-HLA antibody detection with flow beads assays. , 2016, Human immunology.

[12]  M. Bots,et al.  How can we reduce costs of solid‐phase multiplex‐bead assays used to determine anti‐HLA antibodies? , 2016, HLA.

[13]  G. Pantaleo,et al.  Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation. , 2016, Human immunology.

[14]  James Robinson,et al.  Minimum information for reporting next generation sequence genotyping (MIRING): Guidelines for reporting HLA and KIR genotyping via next generation sequencing. , 2015, Human immunology.

[15]  V. Sharma,et al.  Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure , 2015, Transplantation.

[16]  J. Scoazec,et al.  Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. , 2015, Journal of the American Society of Nephrology : JASN.

[17]  L. Kamal,et al.  Pretransplant Immunologic Risk Assessment of Kidney Transplant Recipients With Donor-Specific Anti–Human Leukocyte Antigen Antibodies , 2014, Transplantation.

[18]  L. Sharples,et al.  Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation. , 2014, Kidney international.

[19]  C. Jacquelinet,et al.  Denatured Class I Human Leukocyte Antigen Antibodies in Sensitized Kidney Recipients: Prevalence, Relevance, and Impact on Organ Allocation , 2014, Transplantation.

[20]  R. Bray,et al.  HLA Antibody Detection With Solid Phase Assays: Great Expectations or Expectations Too Great? , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  P. Gourraud,et al.  Validation of statistical imputation of allele-level multilocus phased genotypes from ambiguous HLA assignments. , 2014, Tissue antigens.

[22]  J. Friedewald,et al.  Epitope Analysis of HLA-DQ Antigens: What Does the Antibody See? , 2014, Transplantation.

[23]  N. Maillard,et al.  Solid‐Phase Bead‐Based Assays Limitations Are Not Restricted to Interlaboratory Variability , 2013, American Journal of Transplantation.

[24]  P. Nickerson,et al.  Comprehensive Assessment and Standardization of Solid Phase Multiplex‐Bead Arrays for the Detection of Antibodies to HLA‐Drilling Down on Key Sources of Variation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  Loren Gragert,et al.  Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. , 2013, Human immunology.

[26]  X. Jouven,et al.  Complement-binding anti-HLA antibodies and kidney-allograft survival. , 2013, The New England journal of medicine.

[27]  M. Gandhi,et al.  Lot‐to‐lot variability in HLA antibody screening using a multiplexed bead‐based assay , 2013, Transfusion.

[28]  P S Heeger,et al.  Comprehensive Assessment and Standardization of Solid Phase Multiplex‐Bead Arrays for the Detection of Antibodies to HLA , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  C. Weinstock,et al.  The complement‐mediated prozone effect in the Luminex single‐antigen bead assay and its impact on HLA antibody determination in patient sera , 2013, International journal of immunogenetics.

[30]  A. Webster,et al.  Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation , 2013, Transplantation.

[31]  Greg Bennett,et al.  High Transplant Rates of Highly Sensitized Recipients With Virtual Crossmatching in Kidney Paired Donation , 2012, Transplantation.

[32]  M. González-Escribano,et al.  Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  S G E Marsh,et al.  A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. , 2011, Tissue antigens.

[34]  A. Ender,et al.  HLA Antibody Specification Using Single-Antigen Beads—A Technical Solution for the Prozone Effect , 2011, Transplantation.

[35]  H. Wallerand,et al.  Interpretation of Positive Flow Cytometric Crossmatch in the Era of the Single-Antigen Bead Assay , 2011, Transplantation.

[36]  Dominique Charron,et al.  Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. , 2010, Journal of the American Society of Nephrology : JASN.

[37]  T. Mohanakumar,et al.  Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation. , 2010, Human immunology.

[38]  G. Böhmig,et al.  Clinical relevance of preformed C4d‐fixing and non‐C4d‐fixing HLA single antigen reactivity in renal allograft recipients , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[39]  A. Zachary,et al.  Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. , 2009, Human immunology.

[40]  P. Terasaki,et al.  The Importance of Anti‐HLA‐Specific Antibody Strength in Monitoring Kidney Transplant Patients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[41]  J. Lunz,et al.  Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[42]  P. Terasaki,et al.  Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens. , 2009, Clinical transplants.